Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 10—October 2012
Dispatch

Orthobunyavirus Antibodies in Humans, Yucatan Peninsula, Mexico

Bradley J. BlitvichComments to Author , Rungrat Saiyasombat, Lourdes G. Talavera-Aguilar, Julian E. Garcia-Rejon, Jose A. Farfan-Ale, Carlos Machain-Williams, and Maria A. Loroño-Pino
Author affiliations: Iowa State University College of Veterinary Medicine, Ames, Iowa, USA (B.J. Blitvich, R Saiyasombat); and Universidad Autónoma de Yucatán Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Mérida, México (L.G. Talavera-Aguilar, J.E. Garcia-Rejon, J.A. Farfan-Ale, C. Machain-Williams, M.A. Loroño-Pino)

Main Article

Table

Endpoint titers of serum samples collected from persons in Mexico and analyzed by using comparative PRNT*

Patient 
ID no. Demographic characteristics
PRNT90 titers
Diagnosis
Residence Age, y/sex CVV CHLV KRIV SOURV MAGV WYOV
28 Yucatan 18/M 80 20 – – 40 – UND
34 Yucatan 39/F 80 20 – – 20 – CVV
52 Quintana Roo 39/F 160 – – 40 80 – UND
54 Yucatan 32/M 40 20 – – 40 – UND
62 Yucatan 44/M 40 – – 20 20 – UND
72 Yucatan 23/M 80 – – – 40 – UND
81 Yucatan 60/F 20 20 – 20 – – UND
92 Yucatan 13/M 160 20 – 20 80 – UND
93 Yucatan 42/F 40 20 – – 20 – UND
113 Yucatan 24/F 20 – – – – – UND
114 Yucatan 29/F 40 – – – 20 – UND
120 Yucatan 60/F 20 – – 320 – – SOURV or
SOURV-like virus
159 Yucatan 54/M 20 – – – 20 – UND
161 Yucatan 53/M 20 20 – – – – UND
163 Yucatan 27/F 160 80 40 – 40 – UND
167 Yucatan 16/M 160 – – – 40 – CVV
183 Yucatan 69/F 20 – – – 20 – UND
184 Yucatan 34/M 160 40 – – 80 – UND
185 Yucatan 25/F 20 – – – – – UND
192 Campeche 54/F 80 40 – – 20 – UND
193 Yucatan 16/F 80 – – – 20 – CVV
194 Yucatan 69/F 20 – – 20 – – UND
200 Yucatan 3/F 40 – – 40 40 – UND
205 Yucatan 53/M 40 – – 20 20 – UND
208 Yucatan 57/F 20 160 – – – – CHLV
210 Yucatan 42/M 20 – – – 20 – UND
224 Yucatan 34/M 20 20 – 20 – – UND
234 Yucatan 39/F 20 80 – – 20 – CHLV
236 Yucatan 74/F 20 – – 20 – – UND
386 Yucatan 14/F 20 – – 20 – – UND
388 Yucatan 60/M 160 1,280 160 – 40 – CHLV
389 Yucatan 5/M 20 – – 20 – – UND
390 Yucatan 33/M 40 20 40 20 40 – UND
392 Yucatan 22/M 20 – – – – – UND
393 Yucatan 29/M 40 20 – – 40 – UND
396 Yucatan 34/F 80 – – – 20 – CVV
397 Yucatan 32/M 80 – – – 40 – UND
399 Yucatan 27/M 320 1,280 160 – 320 – CHLV
400 Yucatan 37/F 20 – – – – – UND
401 Yucatan 30/F 160 – – – 40 – CVV
402 Yucatan 18/M 20 – – – 20 – UND
403 Yucatan 50/F 20 20 – – – – UND
407 Yucatan 27/M 80 20 – – 40 – UND
408 Yucatan 40/F 20 – – – – – UND
412 Yucatan 60/M 20 320 80 40 40 – CHLV
415 Yucatan 17/F 20 – – 20 – – UND
420 Yucatan 16/F 160 – – – 20 – CVV
429 Yucatan 37/F 20 – – – – – UND
442 Yucatan 10/F 20 40 – 20 – – UND
455 Yucatan 30/F 20 – – 20 20 – UND

*PRNT, plaque reduction neutralization test; CVV, Cache Valley virus; CHLV, Cholul virus; KRIV, Kairi virus; SOURV, South River virus; MAGV, Maguari virus, WYOV, Wyeomyia virus; –, titer <20; UND, undetermined orthobunyavirus.

Main Article

Page created: September 14, 2012
Page updated: September 14, 2012
Page reviewed: September 14, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external